Clinical Trial Update: Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating apricitabine and tipranavir when dosed alone and in combination for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Apricitabine (Apricitabine)
• Tipranavir (tipranavir)

Snippet

Sponsor: Avexa | Conditions: HIV Infection | Phase 1 | Status: COMPLETED